| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025414 |
| Receipt No. | R000029256 |
| Official scientific title of the study | Safety evaluation of an excessive consumption of Bilberry extract and Lutein |
| Date of disclosure of the study information | 2016/12/26 |
| Last modified on | 2017/12/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Safety evaluation of an excessive consumption of Bilberry extract and Lutein | |
| Title of the study (Brief title) | Safety evaluation of an excessive consumption of Bilberry extract and Lutein | |
| Region |
|
|
| Condition | ||
| Condition | Nothing (healthy subject) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety of excessive consumption of Bilberry extract and Lutein |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Hematologic test (0w,2w,4w,6w) |
| Key secondary outcomes | Body measurement(0w,6w)
Blood biochemical test (0w,2w,4w,6w) Urine analysis (0w,2w,4w,6w) Doctor's questions (0w,6w) Adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Bilberry extract 240mg and Lutein 120mg,4weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Healthy Japanese males and females
2. BMI>=18.5 and <25 kg/m2 |
|||
| Key exclusion criteria | 1. Subjects who have at least one previous medical history of malignant tumor, heart failure or myocardial infarction
2. Subjects who are patient or have history of cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Subjects who have undergone gastrointestinal tract surgery; except appendectomy 4. Subjects who are currently taking medicines (include herbal medicines) and/or supplements 5. Subjects who are allergic to medicines or the test material of this trial 6. Subjects who are or are possibly pregnant, or are lactating 7. Subjects who participate in other clinical trials in the past 3 months 8. Subjects who work time is irregular 9. Subjects who have been determined ineligible by principal investigator for other reasons |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Marie Kosehira |
| Organization | Omnica Co.,Ltd |
| Division name | Research and development Dept. |
| Address | TN Koishikawa BLDG. 5F, 1-15-17 Koishikawa, Bunkyo-ku, Tokyo, JAPAN |
| TEL | 03-5840-9811 |
| kosehira@omnica.co.jp | |
| Public contact | |
| Name of contact person | Marie Kosehira |
| Organization | Omnica Co.,Ltd |
| Division name | Research and development Dept. |
| Address | TN Koishikawa BLDG. 5F, 1-15-17 Koishikawa, Bunkyo-ku, Tokyo, JAPAN |
| TEL | 03-5840-9811 |
| Homepage URL | |
| kosehira@omnica.co.jp | |
| Sponsor | |
| Institute | Omnica Co.,Ltd |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Omnica Co.,Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人財団 百葉の会 銀座医院(東京) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029256 |